US FDA’s Woodcock ‘Managing As If She’s Been Commissioner,’ Not Afraid To Act, CBER Director Says

Peter Marks says Acting Commissioner Janet Woodcock’s tenure running the FDA has been no different than if a permanent commissioner were in place.

CBER Director Peter Marks says that Janet Woodcock is not acting like an acting commissioner. • Source: Nielsen Hobbs; the Pink Sheet | Getty, Alamy images

More from US FDA

More from Agency Leadership